查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198661

套管針市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Trocars Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），套管針市場預計將以近 4.2% 的複合年增長率增長。

COVID-19 大流行在短期內對市場產生了重大影響。 為了遏制冠狀病毒的傳播，許多擇期手術已被取消或推遲。 這導致行業對套管針的需求減少。 因此，在一定程度上沖擊了全球套管針市場。 例如，根據 2021 年 4 月的研究“COVID-19 對胃腸道手術結果的影響”，COVID-19 大流行正在推動各種外科胃腸道疾病治療的範式轉變。 由於越來越多的SARS-CoV-2感染患者需要住院和重症監護，世界各地的各個外科部門都推遲了擇期手術，為COVID-19患者預留醫療資源。 如上所述，許多腹部手術如急性闌尾炎和急性鈣化性膽囊炎被推遲。 根據手術的緊迫性、COVID-19 患者的住院負擔以及醫療資源的可用性，優先選擇擇期手術。 因此，COVID-19 對套管針市場產生了重大影響。

糖尿病、心血管疾病和肥胖等慢性病的負擔在世界範圍內迅速增加。 這些慢性疾病影響了很大一部分人口，導致全世界外科手術的數量不斷增加。 例如，根據美國心臟協會的 Heart & Stroke Statistics 2020 Update，美國每年發生超過 356,000 例院外心臟驟停 (OHCA)，其中 90% 以上是致命性增加。 非創傷性 OHCA 的年發病率估計為 356,461 例，每天約 1,000 例。 為此，心血管手術的需求有望增加，套管針的需求也有望相應增加。 預計這將在預測期內推動市場增長。

此外，不斷增長的老年人口可能會推動行業對套管針的需求，因為老年人口容易患慢性病，而且大多數外科手術都是在老年人口上進行的。 例如，根據國家生物技術信息中心 2022 年發表的一篇題為“在 COVID-19 大流行期間推遲手術的老年外科患者的心理困擾”的論文，大約 53% 的外科手術是在老年患者身上進行的65 歲及以上。正在為 此外，根據 2022 年歐盟統計局的數據，到 2021 年，超過五分之一 (20.8%) 的歐盟人口將超過 65 歲。 因此，預計老年人口的增加將推動該行業對外科手術的需求。 因此，由於上述因素，套管針市場有望在預測期內實現健康增長。

Trockers 市場趨勢

泌尿外科手術有望在預測期內顯著增長

由於良性前列腺增生（BPH）、腎囊腫、囊性腎病、慢性腎病和盆腔癌等泌尿外科疾病的高發，泌尿外科手術在預測期內將出現顯著增長。被認為是高度可能。 根據 Onecia Benjamin 和 Sarah L. Lappin 的一篇論文，終末期腎病 (ESRD) 每年影響美國超過 500,000 人。 此外，美國國家糖尿病、消化和腎臟疾病研究所 (NIDDK) 2020 年的一份報告發現，每年在美國，71% 的終末期腎病 (ESRD) 患者需要透析治療，其餘 29%他說他需要換腎。

此外，根據2021年12月發表在《軍事醫學研究》雜誌上的論文《1990年至2019年203個國家和地區尿路感染、尿路結石和良性前列腺增生的流行病學趨勢》，在印度，泌尿外科疾病影響許多人。 據報導，該國的尿路感染、尿路結石和良性前列腺增生症發病率最高。 因此，泌尿系統疾病的高患病率需要適當的疾病管理，包括手術。 因此，預計在研究期間對套管針的需求會增加，因為它們是必不可少的手術器械。 因此，由於上述因素，預計該行業在預測期內將出現顯著增長。

預計在預測期內北美將主導套管針市場

在預測期內，北美的套管針市場可能會出現顯著增長。 在北美，美國占據了相當大的市場份額，預計在預測期內仍將佔據主導地位。 這可以歸因於諸如癌症、泌尿系統疾病、糖尿病和心血管疾病等疾病日益流行等因素。 根據美國疾病控制與預防中心 (CDC) 提供的統計數據，2021 年 9 月更新的數據顯示，到 2030 年，美國房顫預計將影響 1210 萬人。 此外，肥胖正變得越來越普遍，減肥手術已被證明可有效控制肥胖。 因此，肥胖可能會導致每年進行更多的減肥手術。 例如，根據 2021 年 6 月更新的太平洋減肥統計數據，2020 年美國進行了約 297,000 例減肥手術。 這些統計數據表明，減肥手術越來越受歡迎，並將在研究期間增加對套管針的需求。

一些市場參與者致力於實施戰略舉措，從而為該地區的發展做出貢獻。 例如，2020年12月，CONMED在美國推出了Core Entree II Trocar型號。 同時，2021 年 5 月，Fannin Ltd 推出了 Espiner Trocar 系列。 因此，由於上述因素，北美有望在預測期內主導套管針市場。

Trocker 市場的競爭對手分析

該行業的主要公司有 B. Braun Melsungen AG、CONMED Corporation、Genicon Inc、Johnson & Johnson、LaproSurge、Medtronic PLC、Molnlycke Health Care AB、Purple Surgical、Teleflex Incorporated、The Cooper Companies.Inc、Ackermann Instrumente GmbH、BNR 和 Conmed Corp.

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對微創手術的需求不斷擴大
    • 慢性病和肥胖症患病率上升
    • 腹腔鏡領域技術進展
  • 市場製約因素
    • 與使用套管針相關的並發症
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 一次性Trocker
    • 可重複使用的套管針
  • 按芯片類型
    • 無葉搖臂
    • 光學套管針
    • 直截了當的特羅克
    • 刀鋒戰士
  • 通過使用
    • 普通外科
    • 婦科手術
    • 泌尿外科
    • 其他手術
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • B. Braun Melsungen AG
    • CONMED Corporation
    • Genicon Inc.
    • Johnson & Johnson
    • LaproSurge
    • Medtronic PLC
    • Molnlycke Health Care AB
    • Purple Surgical
    • Teleflex Incorporated
    • The Cooper Companies Inc.
    • Ackermann Instrumente GmbH
    • BNR Co.Ltd.
    • Conmed Corp.

第7章 市場機會今後動向

簡介目錄
Product Code: 67656

The trocars market is expected to register a CAGR of nearly 4.2% during the forecast period (2022-2027).

The COVID-19 pandemic had a significant impact on the market in the short term. A large number of elective surgeries were canceled or postponed to reduce the spread of the coronavirus. This leads to a decrease in demand for trocars in the industry. Thus, it has affected the global trocars market to a certain extent. For instance, according to the study "Impact of COVID-19 on the Outcomes of Gastrointestinal Surgery" published in April 2021, the COVID-19 pandemic has brought a paradigm shift in the treatment of various surgical gastrointestinal disorders. Various surgical departments around the world postponed elective surgeries to spare health resources for COVID-19 patients due to the rising number of patients requiring hospitalization and critical care for SARS-CoV-2 infections. As per the above-mentioned study, many abdominal surgeries, such as those for acute appendicitis and acute calculous cholecystitis, have been postponed. Elective procedures were prioritized based on the surgical procedure's urgency, the COVID-19 patients' hospital burden, and the availability of healthcare resources. Thus, COVID-19 has a significant impact on the trocars market.

The burden of chronic diseases such as diabetes, cardiovascular diseases, and obesity is rapidly increasing around the world. These chronic diseases are affecting a large proportion of the population and thus increasing the number of surgical procedures across the world. For instance, according to the American Heart Association's Heart & Stroke Statistics 2020 Update, there are more than 356,000 out-of-hospital cardiac arrests (OHCA) in the United States each year, with over 90% of these being fatal. The annual incidence of non-traumatic OHCA is estimated to be 356,461, or about 1,000 people each day. This is expected to increase the demand for cardiovascular surgeries and thereby rise in demand for trocars in the industry. This is expected to drive market growth over the forecast period.

Additionally, the rise in the geriatric population is likely to drive the demand for trocars in the industry as the geriatric population is more prone to chronic diseases, and most of the surgical procedures are performed on the geriatric population. For instance, according to the article published by the National Center for Biotechnology Information, titled 'Psychological distress among elderly surgical patients who had their surgery postponed during the COVID-19 pandemic' in 2022, approximately 53% of all surgical procedures are performed on patients over the age of 65. Additionally, as per Eurostat in 2022, more than one-fifth (20.8 %) of the European Union population was aged 65 and over 2021. Thus, the rise in the geriatric population is expected to drive the demand for surgical procedures in the industry. Thus, owing to the aforementioned factors, the trocars market is expected to register healthy growth over the forecast period.

Trocars Market Trends

Urological Surgery is Expected to Exhibit Significant Growth Over the Forecast Period

Urological surgery is likely to witness significant growth during the forecast period owing to a high incidence of urologic conditions such as benign prostatic hyperplasia (BPH), renal cyst, cystic kidney diseases, chronic kidney disease, pelvic cancer, etc. According to the article published in the National Institutes of Health in September 2021 by Onecia Benjamin and Sarah L. Lappin., End-stage renal disease (ESRD) affects more than 500,000 persons in the United States annually. Furthermore, according to the National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) Report in 2020, people with end-stage renal disease (ESRD) require 71% of dialysis treatment, and the remaining 29% need a kidney transplant in the United States annually.

Moreover, as per an article titled "Epidemiological Trends Of Urinary Tract Infections, Urolithiasis and Benign Prostatic Hyperplasia in 203 Countries and Territories from 1990 to 2019" published in the Journal of 'Military Medical Research' in December 2021, in India, urology diseases affected a large number of people. The country reported the highest incidences of urinary tract infections, urolithiasis, and benign prostatic hyperplasia. Therefore, the high prevalence of urological diseases will require proper disease management including surgery. As a result, the demand for trocars is expected to increase during the study period as it is an essential surgical tool. Therefore, owing to the aforementioned factors, the segment is expected to attain significant growth over the forecast period.

North America is Expected to Dominate the Trocars Market Over the Forecast Period

North America is likely to witness significant growth in the trocars market during the forecast period. Within North America, the United States holds a substantial share of the market, and it is expected to dominate over the forecast period. This can be attributed to the factors such as the increase in the prevalence of diseases such as cancer, urological diseases, diabetes, and cardiovascular diseases among others. As per the statistics provided by the Centre for Disease Control and Prevention (CDC), data updated in September 2021, in the United States, atrial fibrillation is anticipated to affect 12.1 million people by 2030. Additionally, obesity is becoming more common, and bariatric surgery has shown to be a successful way to manage it. As a result, due to obesity, there will likely be more bariatric procedures carried out annually. For instance, according to the Pacific Bariatric statistics data updated in June 2021, in 2020, around 297,000 bariatric surgeries were performed in the United States. These statistics indicate that bariatric surgeries are becoming more and more common, which will increase demand for trocars during the study period.

Several market players are engaged in implementing strategic initiatives, thereby contributing to the region's growth. For instance, In December 2020, CONMED launched Core Entree II Trocar model in the United States. On the other hand, in May 2021, Fannin Ltd launched the Espiner Trocar range. Thus, due to the factors mentioned above, North America is expected to dominate the trocars market over the forecast period.

Trocars Market Competitor Analysis

Key players operating in the industry are B. Braun Melsungen AG, CONMED Corporation, Genicon Inc., Johnson & Johnson, LaproSurge, Medtronic PLC, Molnlycke Health Care AB, Purple Surgical, Teleflex Incorporated, The Cooper Companies Inc., Ackermann Instrumente GmbH, BNR Co.Ltd., and Conmed Corp.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand for Minimally-Invasive Surgery
    • 4.2.2 Rising Prevalence of Chronic Diseases and Obesity
    • 4.2.3 Technological Advancements in the Field of Laparoscopy
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated With the Use of Trocars
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Disposable Trocars
    • 5.1.2 Reusable Trocars
  • 5.2 By Tip Type
    • 5.2.1 Bladeless Trocars
    • 5.2.2 Optical Trocars
    • 5.2.3 Blunt Trocars
    • 5.2.4 Bladed Trocars
  • 5.3 By Application
    • 5.3.1 General Surgery
    • 5.3.2 Gynaecological Surgery
    • 5.3.3 Urological Surgery
    • 5.3.4 Other Surgeries
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 CONMED Corporation
    • 6.1.3 Genicon Inc.
    • 6.1.4 Johnson & Johnson
    • 6.1.5 LaproSurge
    • 6.1.6 Medtronic PLC
    • 6.1.7 Molnlycke Health Care AB
    • 6.1.8 Purple Surgical
    • 6.1.9 Teleflex Incorporated
    • 6.1.10 The Cooper Companies Inc.
    • 6.1.11 Ackermann Instrumente GmbH
    • 6.1.12 BNR Co.Ltd.
    • 6.1.13 Conmed Corp.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS